Evan Robert Myers, MD, MPH

AddThis

Print

email this


Professor of Obstetrics and Gynecology
Chief of the Division of Clinical & Epidemiologic Research
Department / Division:
Obstetrics/Gynecology / OB/Gyn-Clinical & Epidemiologic Research
Address:
244 Baker House
Durham, NC 27710
Office Telephone:
(919) 668-0296
Training:
  • MD, University of Pennsylvania, 1988
  • MPH, University of North Carolina at Chapel Hill, 1992
Residency:
  • House Staff - Resident, Ob/Gyn, Duke University
Research Interests:
My research interests are broadly in the application of quantitative methods, especially mathematical modeling and decision analysis, to problems in women's health. Recent and current activities include integration of simulation modeling and systematic reviews to inform decisions surrounding cervical, ovarian, and breast cancer prevention and control, screening for postpartum depression, and management of uterine fibroids.    We are also engaged in exploring methods for integrating guidelines development and research prioritization.    In addition, I have ongoing collaborations using the tools of decision analysis with faculty in other clinical areas  Research is conducted through the Division of Clinical and Epidemiological Research in the Department of Obstetrics and Gynecology, the Evidence Synthesis Group in the Duke Clinical Research Institute, and the Duke Cancer Institute.
Representative Publications:
  • Legro, RS; Barnhart, HX; Schlaff, WD; Carr, BR; Diamond, MP; Carson, SA; Steinkampf, MP; Coutifaris, C; McGovern, PG; Cataldo, NA; Gosman, GG; Nestler, JE; Giudice, LC; Leppert, PC; Myers, ER; Cooperative Multicenter Reproductive Medicine Network. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. New England Journal of Medicine. 2007;356:551-566.  Abstract
  • McGovern, PG; Legro, RS; Myers, ER; Barnhart, HX; Carson, SA; Diamond, MP; Carr, BR; Schlaff, WD; Coutifaris, C; Steinkampf, MP; Nestler, JE; Gosman, G; Leppert, PC; Giudice, LC; National Institutes for Child Health and Human Development-Reproductive Medicine Network. Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome. Fertility and Sterility. 2007;87:442-444.  Abstract
  • Bidus, MA; Maxwell, GL; Kulasingam, S; Rose, GS; Elkas, JC; Chernofsky, M; Myers, ER. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening. Obstetrics and Gynecology. 2006;107:997-1005.  Abstract
  • Flynn, M; Jamison, M; Datta, S; Myers, E. Health care resource use for uterine fibroid tumors in the United States. American Journal of Obstetrics and Gynecology. 2006;195:955-964.  Abstract
  • James, AH; Jamison, MG; Biswas, MS; Brancazio, LR; Swamy, GK; Myers, ER. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation. 2006;113:1564-1571.  Abstract
  • James, AH; Jamison, MG; Brancazio, LR; Myers, ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. American Journal of Obstetrics and Gynecology. 2006;194:1311-1315.  Abstract
  • Kulasingam, SL; Kim, JJ; Lawrence, WF; Mandelblatt, JS; Myers, ER; Schiffman, M; Solomon, D; Goldie, SJ; ALTS Group. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of National Cancer Institute. 2006;98:92-100.  Abstract
  • Kulasingam, SL; Myers, ER; Lawson, HW; McConnell, KJ; Kerlikowske, K; Melnikow, J; Washington, AE; Sawaya, GF. Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstetrics and Gynecology. 2006;107:321-328.  Abstract
  • Havrilesky, LJ; Kulasingam, SL; Matchar, DB; Myers, ER. FDG-PET for management of cervical and ovarian cancer. Gynecologic Oncology. 2005;97:183-191.  Abstract
  • James, AH; Bushnell, CD; Jamison, MG; Myers, ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstetrics and Gynecology. 2005;106:509-516.  Abstract
  • Myers, ER; Goodwin, S; Landow, W; Mauro, M; Peterson, E; Pron, G; Spies, JB; Worthington-Kirsch, R; FIBROID Investigators. Prospective data collection of a new procedure by a specialty society: the FIBROID registry. Obstetrics and Gynecology. 2005;106:44-51.  Abstract
  • Myers, ER; Silva, SG; Hafley, G; Kunselman, AR; Nestler, JE; Legro, RS; National Institute of Child Health and Human Development Reproductive Medicine Network. Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial. Contemporary Clinical Trials. 2005;26:271-280.  Abstract
  • Spies, JB; Myers, ER; Worthington-Kirsch, R; Mulgund, J; Goodwin, S; Mauro, M; FIBROID Registry Investigators. The FIBROID Registry: symptom and quality-of-life status 1 year after therapy. Obstetrics and Gynecology. 2005;106:1309-1318.  Abstract
  • Worthington-Kirsch, R; Spies, JB; Myers, ER; Mulgund, J; Mauro, M; Pron, G; Peterson, ED; Goodwin, S; FIBROID Investigators. The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes. Obstetrics and Gynecology. 2005;106:52-59.  Abstract
  • Coutifaris, C; Myers, ER; Guzick, DS; Diamond, MP; Carson, SA; Legro, RS; McGovern, PG; Schlaff, WD; Carr, BR; Steinkampf, MP; Silva, S; Vogel, DL; Leppert, PC; NICHD National Cooperative Reproductive Medicine Network. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertility and Sterility. 2004;82:1264-1272.  Abstract
  • Fretts, RC; Elkin, EB; Myers, ER; Heffner, LJ. Should older women have antepartum testing to prevent unexplained stillbirth?. Obstetrics and Gynecology. 2004;104:56-64.  Abstract
  • James, A; Matchar, DB; Myers, ER. Testing for von Willebrand disease in women with menorrhagia: a systematic review. Obstetrics and Gynecology. 2004;104:381-388.  Abstract
  • Kulasingam, SL; Myers, ER. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA: Journal of the American Medical Association. 2003;290:781-789.  Abstract
  • Roth, TM; Gustilo-Ashby, T; Barber, MD; Myers, ER. Effects of race and clinical factors on short-term outcomes of abdominal myomectomy. Obstetrics and Gynecology. 2003;101:881-884.  Abstract
  • Sawaya, GF; McConnell, KJ; Kulasingam, SL; Lawson, HW; Kerlikowske, K; Melnikow, J; Lee, NC; Gildengorin, G; Myers, ER; Washington, AE. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. New England Journal of Medicine. 2003;349:1501-1509.  Abstract
  • Maxwell, GL; Carlson, JW; Ochoa, M; Krivak, T; Rose, GS; Myers, ER. Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries. Obstetrics and Gynecology. 2002;100:740-748.  Abstract
  • Myers, ER; Barber, MD; Gustilo-Ashby, T; Couchman, G; Matchar, DB; McCrory, DC. Management of uterine leiomyomata: what do we really know?. Obstetrics and Gynecology. 2002;100:8-17.  Abstract
  • Visco, AG; Taber, KH; Weidner, AC; Barber, MD; Myers, ER. Cost-effectiveness of universal cystoscopy to identify ureteral injury at hysterectomy. Obstetrics and Gynecology. 2001;97:685-692.  Abstract
  • Myers, ER; McCrory, DC; Nanda, K; Bastian, L; Matchar, DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. American Journal of Epidemiology. 2000;151:1158-1171.  Abstract
  • Myers, ER; McCrory, DC; Subramanian, S; McCall, N; Nanda, K; Datta, S; Matchar, DB. Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening. Obstetrics and Gynecology. 2000;96:645-652.  Abstract
  • Myers, ER; Steege, JF. Risk adjustment for complications of hysterectomy: limitations of routinely collected administrative data. American Journal of Obstetrics and Gynecology. 1999;181:567-575.  Abstract
  • Myers, ER; Thompson, JW; Simpson, K. Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy. Obstetrics and Gynecology. 1998;91:174-181.  Abstract